Evaluation of Endoscopic Treatment of Zenker's Diverticulum Using LigaSure (NCT01739426) | Clinical Trial Compass
CompletedNot Applicable
Evaluation of Endoscopic Treatment of Zenker's Diverticulum Using LigaSure
France10 participantsStarted 2013-03
Plain-language summary
The primary objective of this study is to evaluation the success of endoscopic treatment of Zenker's diverticulum using a LigaSure device (thermal fusion of vessels) via a measure of swallowing function at 12 months post-surgery.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* The patient must have given his/her informed and signed consent
* The patient must be insured or beneficiary of a health insurance plan
* The patient is available for 12 months of follow-up
* The patient has a Zenkers diverticulum as confirmed by a pharyngo-oesophagean transit test, regardless of van Overbeek classification
Exclusion Criteria:
* The patient is participating in another study
* The patient is in an exclusion period determined by a previous study
* The patient is under judicial protection, under tutorship or curatorship
* The patient (or his/her person-of-trust) refuses to sign the consent
* It is impossible to correctly inform the patient
* The patient does not read french
* The patient is pregnant
* The patient is breastfeeding
* The patients has a contraindication for a treatment necessary for this study, or for general anesthesia
* The patent has a history of complications related to hemostasis
* The preoperative checkup indicates potential for hemostasis related problems
What they're measuring
1
Operational success according to the van Overbeek classification (yes/no)